Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irving W Wainer

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Scientific Reports|March 8, 2022
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β<sub>2</sub> adrenergic agonistArtur Wnorowski, Danuta Dudzik, Michel Bernier, et al.
Bioorganic & Medicinal Chemistry|December 4, 2014
Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptorKrzysztof Jozwiak, Katarzyna M Targowska-Duda, Agnieszka A Kaczor, et al.
Acta Pharmacologica Sinica|January 16, 2019
Discovery of β-arrestin-biased β<sub>2</sub>-adrenoceptor agonists from 2-amino-2-phenylethanol derivativesAnthony Yiu-Ho Woo, Xin-Yue Ge, Li Pan, et al.
Psychopharmacology|July 25, 2014
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depressionRuin Moaddel, David A Luckenbaugh, Ying Xie, et al.
The Journal of Biological Chemistry|May 17, 2014
Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptorAnthony Yiu-Ho Woo, Krzysztof Jozwiak, Lawrence Toll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Journal of Medicinal Chemistry|April 17, 2010
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptorEnrica Calleri, Stefania Ceruti, Gloria Cristalli, et al.
Nature|May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolitesPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Scientific Reports|March 8, 2022
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β<sub>2</sub> adrenergic agonistArtur Wnorowski, Danuta Dudzik, Michel Bernier, et al.
Bioorganic & Medicinal Chemistry|December 4, 2014
Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptorKrzysztof Jozwiak, Katarzyna M Targowska-Duda, Agnieszka A Kaczor, et al.
Acta Pharmacologica Sinica|January 16, 2019
Discovery of β-arrestin-biased β<sub>2</sub>-adrenoceptor agonists from 2-amino-2-phenylethanol derivativesAnthony Yiu-Ho Woo, Xin-Yue Ge, Li Pan, et al.
Psychopharmacology|July 25, 2014
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depressionRuin Moaddel, David A Luckenbaugh, Ying Xie, et al.
The Journal of Biological Chemistry|May 17, 2014
Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptorAnthony Yiu-Ho Woo, Krzysztof Jozwiak, Lawrence Toll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Journal of Medicinal Chemistry|April 17, 2010
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptorEnrica Calleri, Stefania Ceruti, Gloria Cristalli, et al.
Nature|May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolitesPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Pageof 14